Bio-Rad Laboratories Cash Flow Statement Analysis

Operating, investing, and financing activities in billions USD

Scroll to see more
Cash flow statement showing operating, investing, and financing activities for Bio-Rad Laboratories, Inc. (BIO) - Annual data in billions USD
BreakdownFY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018
Period EndingDec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018
Operating Activities
Net Income-1.84-0.64-3.634.253.810.000.37
Depreciation & Amortization0.150.150.140.140.180.000.14
Stock Based Compensation0.060.060.060.050.040.000.00
Change in Working Capital-0.62-0.43-1.610.760.640.490.08
Change in Accounts Receivable0.020.01-0.09-0.02-0.020.000.00
Change in Inventory0.01-0.05-0.160.05-0.050.000.00
Change in Accounts Payable-0.04-0.07-0.100.070.120.000.00
Change in Other Working Capital0.00-0.010.02-0.010.010.000.00
Other Operating Activities0.02-0.010.020.010.000.000.00
Net Cash from Operating Activities0.460.370.190.670.580.460.29
Investing Activities
Capital Expenditures-0.17-0.16-0.110.130.100.10-0.13
Acquisitions0.000.00-0.10-0.13-0.08-0.080.01
Purchases of Investments0.03-0.69-2.06-0.080.120.000.00
Sales/Maturities of Investments-0.020.861.07-0.540.12-0.03-0.07
Other Investing Activities-0.020.000.000.000.000.01-0.19
Net Cash from Investing Activities-0.160.02-1.21-0.80-0.06-0.21-0.19
Financing Activities
Debt Repayment0.000.000.000.00-0.430.000.00
Common Stock Issued0.020.02-0.22-0.05-0.100.02-0.05
Common Stock Repurchased-0.21-0.43-0.22-0.07-0.110.000.00
Other Financing Activities-0.03-0.01-0.01-0.02-0.02-0.01-0.01
Net Cash from Financing Activities-0.22-0.430.97-0.06-0.52-0.02-0.05
Summary
Effect of Forex Changes on Cash0.010.000.00-0.010.010.000.00
Net Change in Cash0.09-0.03-0.04-0.180.000.230.05
Cash at Beginning of Period0.400.430.470.670.660.430.38
Cash at End of Period0.490.400.430.670.670.660.43
Free Cash Flow0.290.220.080.540.480.360.16
Supplemental Disclosures
Interest Paid0.00-0.05-0.020.00-0.02-0.020.00
Income Taxes Paid0.100.13-0.16-0.13-0.07-0.050.00